Jundishapur Journal of Microbiology

Published by: Kowsar

Colonization of Streptococcus pneumoniae in Pneumonia Patients with Lung Cancer

Songwei Zhou 1 and Qiuxia Zhao 1 , *
Authors Information
1 Department of Clinical Laboratory, Xinghua People’s Hospital, Jiangsu, China
Article information
  • Jundishapur Journal of Microbiology: February 2018, 11 (2); e57300
  • Published Online: January 13, 2017
  • Article Type: Research Article
  • Received: July 2, 2017
  • Revised: November 16, 2017
  • Accepted: December 19, 2017
  • DOI: 10.5812/jjm.57300

To Cite: Zhou S, Zhao Q. Colonization of Streptococcus pneumoniae in Pneumonia Patients with Lung Cancer, Jundishapur J Microbiol. 2018 ; 11(2):e57300. doi: 10.5812/jjm.57300.

Abstract
Copyright © 2017, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusion
Footnotes
References
  • 1. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-32. doi: 10.3322/caac.21338. [PubMed: 26808342].
  • 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7-30. doi: 10.3322/caac.21332. [PubMed: 26742998].
  • 3. Rolston KV. The spectrum of pulmonary infections in cancer patients. Curr Opin Oncol. 2001;13(4):218-23. doi: 10.1097/00001622-200107000-00002. [PubMed: 11429477].
  • 4. International Agency for Research on Cancer . GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. WHO; 2013. Available from: http://globocan.iarc.fr/Default.aspx.
  • 5. Han R, Zheng R, Zhang S, Wu M, Chen W. [Trend analyses on the differences of lung cancer incidence between gender, area and average age in China during 1989-2008]. Zhongguo Fei Ai Za Zhi. 2013;16(9):445-51. doi: 10.3779/j.issn.1009-3419.2013.09.02. [PubMed: 24034990].
  • 6. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108. doi: 10.3322/caac.21262. [PubMed: 25651787].
  • 7. Perlin E, Bang KM, Shah A, Hursey PD, Whittingham WL, Hashmi K, et al. The impact of pulmonary infections on the survival of lung cancer patients. Cancer. 1990;66(3):593-6. doi: 10.1002/1097-0142(19900801)66:3<593::AID-CNCR2820660331>3.0.CO;2-R. [PubMed: 2364370].
  • 8. Remiszewski P, Slodkowska J, Wiatr E, Zych J, Radomski P, Rowinska-Zakrzewska E. Fatal infection in patients treated for small cell lung cancer in the Institute of Tuberculosis and Chest Diseases in the years 1980-1994. Lung Cancer. 2001;31(2-3):101-10. doi: 10.1016/S0169-5002(00)00185-9. [PubMed: 11165389].
  • 9. Berghmans T, Sculier JP, Klastersky J. A prospective study of infections in lung cancer patients admitted to the hospital. Chest. 2003;124(1):114-20. doi: 10.1378/chest.124.1.114. [PubMed: 12853512].
  • 10. Sarihan S, Ercan I, Saran A, Cetintas SK, Akalin H, Engin K. Evaluation of infections in non-small cell lung cancer patients treated with radiotherapy. Cancer Detect Prev. 2005;29(2):181-8. doi: 10.1016/j.cdp.2004.11.001. [PubMed: 15829379].
  • 11. Rossini F, Verga M, Pioltelli P, Giltri G, Sancassani V, Pogliani EM, et al. Incidence and outcome of pneumonia in patients with acute leukemia receiving first induction therapy with anthracycline-containing regimens. Haematologica. 2000;85(12):1255-60. [PubMed: 11114131].
  • 12. Meyer E, Beyersmann J, Bertz H, Wenzler-Rottele S, Babikir R, Schumacher M, et al. Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation. Bone Marrow Transplant. 2007;39(3):173-8. doi: 10.1038/sj.bmt.1705561. [PubMed: 17245425].
  • 13. Yoshida M, Akiyama N, Fujita H, Miura K, Miyatake J, Handa H, et al. Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group. Int J Hematol. 2011;93(1):66-73. doi: 10.1007/s12185-010-0746-y. [PubMed: 21213127].
  • 14. Evans SE, Ost DE. Pneumonia in the neutropenic cancer patient. Curr Opin Pulm Med. 2015;21(3):260-71. doi: 10.1097/MCP.0000000000000156. [PubMed: 25784246].
  • 15. Safdar A, Armstrong D. Infectious morbidity in critically ill patients with cancer. Crit Care Clin. 2001;17(3):531-70. vii-viii. doi: 10.1016/S0749-0704(05)70198-6. [PubMed: 11525048].
  • 16. Garcia JB, Lei X, Wierda W, Cortes JE, Dickey BF, Evans SE, et al. Pneumonia during remission induction chemotherapy in patients with acute leukemia. Ann Am Thorac Soc. 2013;10(5):432-40. doi: 10.1513/AnnalsATS.201304-097OC. [PubMed: 23987587].
  • 17. Gonzalez C, Johnson T, Rolston K, Merriman K, Warneke C, Evans S. Predicting pneumonia mortality using CURB-65, PSI, and patient characteristics in patients presenting to the emergency department of a comprehensive cancer center. Cancer Med. 2014;3(4):962-70. doi: 10.1002/cam4.240. [PubMed: 24802800].
  • 18. Garcia-Vidal C, Ardanuy C, Gudiol C, Cuervo G, Calatayud L, Bodro M, et al. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in cancer patients. J Infect. 2012;65(6):521-7. doi: 10.1016/j.jinf.2012.08.015. [PubMed: 22954752].
  • 19. Akinosoglou KS, Karkoulias K, Marangos M. Infectious complications in patients with lung cancer. Eur Rev Med Pharmacol Sci. 2013;17(1):8-18. [PubMed: 23329518].
  • 20. Leal AL, Castaneda E. [Antimicrobial susceptibility of Streptococcus pneumoniae colonizing the nasopharynx of Colombian children with pneumonia]. Rev Panam Salud Publica. 1997;1(4):266-72. doi: 10.1590/S1020-49891997000400002. [PubMed: 9303812].
  • 21. Carratala J, Roson B, Fernandez-Sevilla A, Alcaide F, Gudiol F. Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome. Arch Intern Med. 1998;158(8):868-72. doi: 10.1001/archinte.158.8.868. [PubMed: 9570172].
  • 22. Fukushima K, Kubo T, Ehara N, Nakano R, Matsutake T, Ishimatu Y, et al. A novel method for rapid detection of Streptococcus pneumoniae antigens in blood. J Infect Chemother. 2016;22(3):143-8. doi: 10.1016/j.jiac.2015.12.004. [PubMed: 26778250].
  • 23. Aliberti S, Brock GN, Peyrani P, Blasi F, Ramirez JA, Community-Acquired Pneumonia O. The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia. Int J Tuberc Lung Dis. 2009;13(12):1550-6. [PubMed: 19919775].
  • 24. Duque JL, Ramos G, Castrodeza J, Cerezal J, Castanedo M, Yuste MG, et al. Early complications in surgical treatment of lung cancer: A prospective, multicenter study. Ann Thorac Surg. 1997;63(4):944-50. doi: 10.1016/s0003-4975(97)00051-9.
  • 25. Kearney DJ, Lee TH, Reilly JJ, DeCamp MM, Sugarbaker DJ. Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest. 1994;105(3):753-9. doi: 10.1378/chest.105.3.753. [PubMed: 8131537].
  • 26. Busch E, Verazin G, Antkowiak JG, Driscoll D, Takita H. Pulmonary complications in patients undergoing thoracotomy for lung carcinoma. Chest. 1994;105(3):760-6. doi: 10.1378/chest.105.3.760. [PubMed: 8131538].
  • 27. Deslauriers J, Ginsberg RJ, Piantadosi S, Fournier B. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest. 1994;106(6 Suppl):329S-30S. doi: 10.1378/chest.106.6.329S. [PubMed: 7988256].
  • 28. Dancewicz M, Szymankiewicz M, Bella M, Swiniarska J, Kowalewski J. [Bronchial bacterial colonization in patients with lung cancer]. Pneumonol Alergol Pol. 2009;77(3):242-7. [PubMed: 19591094].
  • 29. Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev. 2002;15(4):613-30. doi: 10.1128/CMR.15.4.613-630.2002. [PubMed: 12364372].
  • 30. Park HK, Lee HJ, Kim W. Real-time PCR assays for the detection and quantification of Streptococcus pneumoniae. FEMS Microbiol Lett. 2010;310(1):48-53. doi: 10.1111/j.1574-6968.2010.02044.x. [PubMed: 20633048].
  • 31. M100-S25 Performance Standards for Antimicrobial Susceptibility Testing, Twenty-Fifth Informational Supplement An informational supplement for global application developed through the Clinical and Laboratory Standards Institute consensus process. 2015.The Clinical and Laboratory Standards Institute.
  • 32. Meena DMD, Shreevidya K. Pulmonary bacterial and fungal infections in cancer patients with neutropaenia. J Clin Diagnostic Res. 2012;5(6):1169-72.
  • 33. Rybojad P, Los R, Sawicki M, Tabarkiewicz J, Malm A. Anaerobic bacteria colonizing the lower airways in lung cancer patients. Folia Histochem Cytobiol. 2011;49(2):263-6. doi: 10.5603/FHC.2011.0036. [PubMed: 21744326].
  • 34. Wang Q, Jin Z, Niu H, Yu C, Wei Z, Yang A. Prevalence and rapid detection of Streptococcus pneumoniae isolated from lung cancer patients with pneumonia infection. Biomed Res. 2017;28(13):1-6.
  • 35. Vento S, Cainelli F, Temesgen Z. Lung infections after cancer chemotherapy. Lancet Oncol. 2008;9(10):982-92. doi: 10.1016/S1470-2045(08)70255-9. [PubMed: 19071255].
  • 36. Thornsberry C, Sahm DF. Antimicrobial resistance in respiratory tract pathogens: results of an international surveillance study. Chemotherapy. 2000;46 Suppl 1:15-23. doi: 10.1159/000048488. [PubMed: 10810209].
  • 37. Musher DM, Dowell ME, Shortridge VD, Flamm RK, Jorgensen JH, Le Magueres P, et al. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N Engl J Med. 2002;346(8):630-1. doi: 10.1056/NEJM200202213460820. [PubMed: 11856810].
  • 38. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis. 1992;14(4):801-7. doi: 10.1093/clinids/14.4.801. [PubMed: 1576274].
  • 39. Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother. 2004;48(6):2101-7. doi: 10.1128/AAC.48.6.2101-2107.2004. [PubMed: 15155207].
  • 40. Aspa J, Rajas O, Rodriguez de Castro F, Blanquer J, Zalacain R, Fenoll A, et al. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Clin Infect Dis. 2004;38(6):787-98. doi: 10.1086/381886. [PubMed: 14999620].
  • 41. Jacobs MR. Streptococcus pneumoniae: epidemiology and patterns of resistance. Am J Med. 2004;117 Suppl 3A:3S-15S. doi: 10.1016/j.amjmed.2004.07.003. [PubMed: 15360092].
  • 42. Karlowsky JA, Thornsberry C, Jones ME, Evangelista AT, Critchley IA, Sahm DF, et al. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). Clin Infect Dis. 2003;36(8):963-70. doi: 10.1086/374052. [PubMed: 12684907].
  • 43. Lanoix JP, Pluquet E, Lescure FX, Bentayeb H, Lecuyer E, Boutemy M, et al. Bacterial infection profiles in lung cancer patients with febrile neutropenia. BMC Infect Dis. 2011;11:183. doi: 10.1186/1471-2334-11-183. [PubMed: 21707992].
  • 44. Irfan S, Idrees F, Mehraj V, Habib F, Adil S, Hasan R. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study. BMC Infect Dis. 2008;8:80. doi: 10.1186/1471-2334-8-80. [PubMed: 18541017].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments